# Propanc Biopharma, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/propanc-biopharma-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 7 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-11-12T04:47:50.336527+00:00 |
| Last reviewed | 2026-11-12T04:47:50.336527+00:00 |

## Identity

- Legal name: Propanc Biopharma, Inc.
- Display name: Propanc Biopharma, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-11-12T04:47:50.336527+00:00 |
| Completeness | 0.318 |
| Record Quality | 0.799 |
| Directors | 0 |
| Committees | 0 |
| Governance events | 3 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | NOT_REVIEWED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Executive leadership

- James Nathanielsz: Chief Executive Officer, and Director [CEO]. Status: current. claim_id=alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:leadership_role:5
- Jeannine Zimmerman: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:leadership_role:6
- Professor Klaus Kutz: Acting Chief Medical Officer. Status: current. claim_id=alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:leadership_role:7

## Governance events

- CEO_ROLE_RECORDED: James Nathanielsz executive of Propanc Biopharma, Inc., effective 2025-09-29. Effective: 2025-09-29. Detected: 2026-11-12T04:47:50.336527+00:00. event_id=alpha:event:transition:1ndzbw6e6nnua
- CFO_ROLE_RECORDED: Jeannine Zimmerman executive of Propanc Biopharma, Inc., effective 2025-09-29. Effective: 2025-09-29. Detected: 2026-11-12T04:47:50.336527+00:00. event_id=alpha:event:transition:siez4oifkdxq
- EXECUTIVE_APPOINTED: Professor Klaus Kutz executive of Propanc Biopharma, Inc., effective 2025-09-29. Effective: 2025-09-29. Detected: 2026-11-12T04:47:50.336527+00:00. event_id=alpha:event:transition:7cpnkof4tb0q

## Scoped resources

- `alpha://company/propanc-biopharma-inc` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record
- `alpha://company/propanc-biopharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=identity
- `alpha://company/propanc-biopharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=corporate-structure
- `alpha://company/propanc-biopharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=board
- `alpha://company/propanc-biopharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=committees
- `alpha://company/propanc-biopharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=leadership
- `alpha://company/propanc-biopharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=ownership
- `alpha://company/propanc-biopharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=financials
- `alpha://company/propanc-biopharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=capital-structure
- `alpha://company/propanc-biopharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=compensation
- `alpha://company/propanc-biopharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=governance
- `alpha://company/propanc-biopharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=shareholder-governance
- `alpha://company/propanc-biopharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=audit
- `alpha://company/propanc-biopharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=legal
- `alpha://company/propanc-biopharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=risk
- `alpha://company/propanc-biopharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=cyber
- `alpha://company/propanc-biopharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=ai-governance
- `alpha://company/propanc-biopharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=agents
- `alpha://company/propanc-biopharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=ecosystem
- `alpha://company/propanc-biopharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=events
- `alpha://company/propanc-biopharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=relationships
- `alpha://company/propanc-biopharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=assessments
- `alpha://company/propanc-biopharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- James Nathanielsz: Chief Executive Officer, and Director. Claim: alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:leadership_role:5. Valid from: 2025-09-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2f2048d125b548e9e0bedff74ebd22a0d5fd3f0b96d57a0cebfadc87cb6ee541.
- Jeannine Zimmerman: Chief Financial Officer. Claim: alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:leadership_role:6. Valid from: 2025-09-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a6f9c7c871196b4728ff1be34f3e25f263849acfb11e6e985463a620dc8df8dd.
- Professor Klaus Kutz: Acting Chief Medical Officer. Claim: alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:leadership_role:7. Valid from: 2025-09-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b2af464013a67c5a9bd9772045f20666bf40fcd49c12e403a23f8282acef39b.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- NOT_ASSERTED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Propanc Biopharma, Inc.. Claim: alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0e641ce698d79d1d62fab87a35acce9ccde9ee5e379f3712d6481fc146e7465e.

## Entity Status

- Public listing published. Claim: alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0e641ce698d79d1d62fab87a35acce9ccde9ee5e379f3712d6481fc146e7465e.

## Published Fact

- US. Claim: alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0e641ce698d79d1d62fab87a35acce9ccde9ee5e379f3712d6481fc146e7465e.

## Security Listing

- PPCB (NASDAQ). Claim: alpha:claim:company:b3e2df69-d1f5-4b85-a4f6-e1ad5e854d33:security_listing:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0e641ce698d79d1d62fab87a35acce9ccde9ee5e379f3712d6481fc146e7465e.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | NOT_ASSERTED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:0e641ce698d79d1d62fab87a35acce9ccde9ee5e379f3712d6481fc146e7465e: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/propanc-biopharma-inc).
- alpha:projection-evidence:document:2f2048d125b548e9e0bedff74ebd22a0d5fd3f0b96d57a0cebfadc87cb6ee541: [PPCB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1517681/000149315225016069/form10-k.htm).
- alpha:projection-evidence:document:a6f9c7c871196b4728ff1be34f3e25f263849acfb11e6e985463a620dc8df8dd: [PPCB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1517681/000149315225016069/form10-k.htm).
- alpha:projection-evidence:document:4b2af464013a67c5a9bd9772045f20666bf40fcd49c12e403a23f8282acef39b: [PPCB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1517681/000149315225016069/form10-k.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/propanc-biopharma-inc)
- [Public Markdown](https://registry.alpha.ac/companies/propanc-biopharma-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/propanc-biopharma-inc?format=jsonld)
- MCP resource: `alpha://companies/propanc-biopharma-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-11-13T03:00:44.706904+00:00; recorded 2026-11-13T03:00:44.706904+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.